Health Services · Medical/Nursing Services · NSE: THYROCARE · data 2026-10-09

Thyrocare Technologies Ltd

Health check: Strong (8.2/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹499.7

Market cap

₹7,973 cr

P/E

45.4

P/B

—

ROE

28.8%

ROCE

34.2%

Debt / equity

0.09

Dividend yield

1.86%

1-year return

21.2%

52-week high

₹662

52-week low

₹342.55

Operating margin

25.3%

Growth

Revenue (last 12 months)	₹876 cr
Net profit (last 12 months)	₹176 cr
Sales growth, 3 years (yearly)	16.3%
Profit growth, 3 years (yearly)	36.2%

Chart patterns

Double top — breakdown (key level ₹505.5)
Golden cross — breakout (key level ₹575.39)

Similar companies

Dr. Agarwal's Health Care Ltd. (AGARWALEYE) · Vijaya Diagnostic Centre Ltd. (VIJAYA) · Metropolis Healthcare Ltd. (METROPOLIS) · Nephrocare Health Services Limited (NEPHROPLUS) · Jeena Sikho Lifecare Limited (JSLL)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open THYROCARE in NSE Scanner →